Related Experiment Video
Updated: Jun 21, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Augmentation and combination strategies in resistant depression
1Department of Psychiatry, University of California School of Medicine, San Francisco, CA, USA.
Abstract:
A minority of patients with depression achieves remission with first-line antidepressant treatment; consequently, a second medication is often added to enhance the effects of the initial agent. The second medication may or may not be another antidepressant. Clinical trials have assessed the efficacy of many agents commonly used for augmentation or combination therapy, but well-designed, large trials with a clear definition of treatment resistance are needed.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Drug Therapy
Antianxiety Medications
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Antidepressant Drugs: Overview
